InvestorsHub Logo
Post# of 251697
Next 10
Followers 56
Posts 1150
Boards Moderated 0
Alias Born 11/12/2005

Re: DFRAI post# 119425

Friday, 05/06/2011 2:42:54 AM

Friday, May 06, 2011 2:42:54 AM

Post# of 251697
From the Tweet I did April 29:

$DNDN $JNJ and $SNY drugs extend median M+ CRPC #prostate pts life from ~18mo in 2003 to ~32mo in 2011, a 78% increase.


It is not in the industry's interest to come up with a cure- the ramifications would be disastrous for research departments , a lot of companies being closed etc



You are overly cynical about biotech entrepreneurs. If they found the cure they'd be the happiest person in the world. The economics would take care of themselves because while the prevalence would go to zero, the incidence refreshes every year.


if you had to administer an insurance pool the pays claims - would you still take that same position? if limited resources existed?



Limited resources do exist. Most of the political conversation on healthcare in America the last two years has been around how to deal with those limited resources. And yes, I'd still want a cure if I was running an insurance pool.


The same equivalent attitude took place in the real estate industry - where a lot of people made bets and countless of bystanders got hurt first by lower real estate values and second by loosing their jobs and their homes - innocent bystanders.



You overstate this, too. There were very few innocent bystanders in the real estate market collapse -- no more as a percentage of homeowners than at any other time. Most people didn't factor in economic risk and inflation when making the decision on having a house. They never asked themselves, "What if gasoline goes to $4/gal? Can I afford to make the 60-minute commute from the house I want to buy?" I still feel sorry for many folks, but they aren't blameless. Even (especially) those of us laregely untouched by the recession who saw what was happening in the commodities market, derivatives markets, and etc. early enough to make smart financial decisions. We should have been much more insistent about reforms. Maybe if we would have, it would have been quite so bad or quite so expensive.

But all that's off topic for this Board, so...





Unless otherwise indicated, this is the personal viewpoint of David
Miller and not necessarily that of Biotech Stock Research, LLC.
We're on Twitter at BiotechStockRsr

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.